Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CD19/BCMA CAR-T Cell Therapy for Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia
NCT07324889Phase 2Not yet recruiting
- Start
- Jan 2026
- Primary completion
- Oct 2027
- Modality
- CAR-T Cells
01
Overview
A Phase 2 trial of CD19 CAR-T cells + BCMA CAR-T cells in warm antibody autoimmune hemolytic anemia (WAIHA). Planned start Jan 2026; status: not yet recruiting.
02
Drugs
CD19 CAR-T cells + BCMA CAR-T cells
03
Conditions
warm antibody autoimmune hemolytic anemia (WAIHA)
Beyond the preview
Go deeper on NCT07324889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07324889.